Mettler-Toledo International Inc at JPMorgan Healthcare Conference Transcript
Hi, everyone. Welcome to our next company presentation. I'm Julia Qin, I work on the Life Science Tools and Diagnostics team at J.P. Morgan. And it is my great pleasure to introduce you to our next company presentation by Mettler. As a reminder, after this session, there is a breakout in the Yorkshire Room.
And with that, I'll turn it over to Shawn. Welcome.
Great. Thank you, Julia, and thank you for everyone for joining us here today. I'd like to provide an update and overview of our growth strategies and an update on some of our key initiatives within these strategies.
Before we get started, though, I'd like to just remind everyone of our forward-looking statements.
We have a strong track record of execution at Mettler-Toledo, and continue to believe we can continue to deliver mid-single-digit sales growth with mid-teens EPS growth.
I'm sometimes asked what is the secret sauce to these results. I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |